Internal Medicine, Pulmonary Disease · Fajardo, PR
NPI
1326144361
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
410 Ave General Valero, Torre Medica San Pablo Suite 304
Fajardo, PR, 00738
Phone (787) 801-5325
Groups this clinician bills Medicare through
Medicare paid, 2024
$6,113
109 services
Medicare patients, 2024
44
Average age 78
Drug cost, 2024
$2.8M
8,615 prescriptions
Company payments, 2025
$390
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Glorimar Santos was code 99213 (office e&m - established), 51 times for 28 patients. In total Glorimar Santos billed 109 services in 12 codes, and Medicare paid $6,113.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 51 | 28 | $58.34 | $2,975 |
| 94010 Pulmonary Function Testing | Office | 12 | 12 | $19.50 | $234 |
| 99203 Office E&M - New | Office | 11 | 11 | $75.26 | $828 |
By year: 2022 $11K for 151 services; 2023 $9,787 for 153 services; 2024 $6,113 for 109 services.
Medicare prescription drug claims, 2024
In 2024, the drug Glorimar Santos prescribed most often to Medicare patients was Levocetirizine Dihydrochloride, with 1,152 prescriptions and refills. In total Glorimar Santos wrote 8,615 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levocetirizine Dihydrochloride Generic | 1,152 | 1,222 | 343 | $12K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 1,115 | 1,129 | 456 | $50K |
| Fluticasone Propionate Generic | 954 | 1,064 | 341 | $17K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 878 | 917 | 191 | $601K |
| Breo Ellipta Fluticasone/Vilanterol | 676 | 691 | 162 | $282K |
| Montelukast Sodium Generic | 609 | 798 | 165 | $6,261 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 543 | 556 | 129 | $272K |
| Levalbuterol Tartrate Hfa Levalbuterol Tartrate | 307 | 308 | 145 | $18K |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 280 | 309 | 93 | $69K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 270 | 290 | 65 | $133K |
| Methylprednisolone Generic | 202 | 202 | 167 | $1,774 |
| Symbicort Budesonide/Formoterol Fumarate | 173 | 177 | 68 | $42K |
| Azithromycin Generic | 125 | 125 | 120 | $1,394 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 113 | 113 | 35 | $75K |
| Spiriva Respimat Tiotropium Bromide | 104 | 107 | 38 | $56K |
Brand drugs: 4,767 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Glorimar Santos $390 ($390 in general payments such as food, travel and fees) from 5 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $169.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.